OPKO Health, Inc. is a diversified healthcare company that seeks to serve unmet patient needs and establish industry-leading positions in large, rapidly growing markets. Our diagnostics business includes BioReference Laboratories, one of the nation's largest clinical laboratories, with a core genetic testing business and a 300 person sales and marketing team to drive growth and leverage new products, including 4KScoreÂŽ prostate cancer test and the ClarosÂŽ 1 point-of-care device, which is capable of in office measurement of PSA within 10 minutes. Our pharmaceutical business features RayaldeeÂŽ, an FDA approved treatment for SHPT in stage 3-4 chronic kidney disease (CKD) patients with vitamin D insufficiency, which was launched in November 2016. Besides nephrology, we have strategic focus on the development of diagnostic and therapeutic agents in urology and endocrinology. Pipelines using the same proprietary platforms, such as the long acting CTP, Reverse-PEGylation, and the ClarosÂŽ 1 immunoassay system are in various stage of discovery, lead molecule validation, early clinical, clinical, and expanded post marketing indications. We invest in development of low risk proven therapeutic targets and utilize validated technology to expand our diagnostic test menu for unmet medical needs. We have production and distribution assets abroad, several strategic investments, and an active business development strategy. We expect our future growth to arise from leveraging our proprietary technology, development strengths, and the pursuit of complementary acquisitions and investments. Source
No articles found.
Health Catalyst is a leading provider of data and analytics technology and service...
Health Catalyst is a leading provider of data a...
CAVU Biotherapies offers a comprehensive solution to prepare for, monitor, and tre...
CAVU Biotherapies offers a comprehensive soluti...
NeuBase Therapeutics, Inc. is developing its modular peptide-nucleic acid antisens...
NeuBase Therapeutics, Inc. is developing its mo...
Sol-Gel is a clinical-stage specialty pharmaceutical company focused on developing...
Sol-Gel is a clinical-stage specialty pharmaceu...
AzurRx BioPharma is a development stage biopharmaceutical company (NASDAQ: AZRX) f...
AzurRx BioPharma is a development stage biophar...
We are ProQR, a company on a mission to create new medicines for patients in need....
We are ProQR, a company on a mission to create ...
Cara Therapeutics is a clinical-stage biopharmaceutical company focused on develop...
Cara Therapeutics is a clinical-stage biopharma...
DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company focused ...
DiaMedica Therapeutics Inc. is a clinical stage...
Proteon Therapeutics is working to deliver a new future for patients and families ...
Proteon Therapeutics is working to deliver a ne...
GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of multiplex molecular di...
GenMark Diagnostics (NASDAQ: GNMK) is a leading...
Join the National Investor Network and get the latest information with your interests in mind.